Navigating AML Remission Strategy

This chapter explores the challenges of sustaining remission in Acute Myeloid Leukemia (AML) patients, detailing various therapeutic approaches and their importance in ongoing patient assessment. It also discusses the role of biological markers and maintenance therapies, examining how clinical trial data informs the duration and effectiveness of treatment.